News

TRICOPHARMING RAISES €480.000 IN A NEW FINANCING ROUND

150 150 marketing

We are grateful and proud to announce that we closed a new financing round last month. We would like to welcome the new partners joining Tricopharming’s capital, PedroDiazMontañez and the two investment funds, KiraVentures and Sancus Capital, which we met thanks to the program organized by Decelera Ventures in September 2021. 

In addition to the investment round, Tricopharming received two support lines in recent months: a NEOTEC financing of €260.000 and an ENISA of the value of €200.000 under the AgroInnpulso financing line.

Tricopharming, based in Barcelona and an experimental R&D centre on the island of Tenerife, was incorporated in October 2018, focusing on improving the productivity of the cultivation of medicinal and aromatic plants through the development of technologies capable of stimulating plant trichomes or plant hairs.

This round is in addition to the 2020 pre-seed round and will drive the market launch, commercialization and development of the new MapStimulants line of bio-agriculture products for medicinal and aromatic plants. One of the star products of this line is Tricostimulant™, a specific biostimulant for medicinal cannabis and fibre hemp crops capable of accelerating production while increasing the content of therapeutic molecules and fibre in the plant, thus increasing crop productivity.

“In this new business stage, our challenge is to enter the international market of agrotech solutions that provide the botanical extracts production sector with more eficiency and eficiency thanks to the application of new technologies to agriculture sector. Agrotech solutions like ours contribute to the positive impact on the environment by achieving greater agricultural sustainability,” says Chiara Sanseverino, co-founder and CFO.

Furthermore, the round aims to boost the internationalisation process and finance the upscaling of the production and commercialisation of the Artennua® product line. Artennua® has been launched on the market after managing to substantially optimise the output of the Artemisia annua plant, thanks to the use of proprietary technology based on plant biostimulation. In this way, we have obtained a unique ingredient with a very high concentration of active ingredients. It has been market in the animal health and natural cosmetics market since 2019.

WE ARE BENEFICIARIES OF THE NEOTEC PROGRAM

150 150 marketing

Finally we can announce that we are on the official list of beneficiaries of the NEOTEC program of the Center for Industrial Technological Development CDTI and the Ministry of Science and Innovation.

This program gives a boost to technology startups like ours to continue growing and developing our projects MAPStimulants and Artennua®. Thanks to this financial support, which is in addition to others previously received by Enisa, MINECO, ICEX and ACCIÓ, we will be able to accelerate our trichome revolution throughout 2022.

In Biotech Tricopharming Research SL, we are very proud to achieve this milestone and we thank the CDTI that once again trusts us. We will make the most of this valuable opportunity.

WE ARE NOW PART OF ICEX NEXT

150 150 marketing

Tricopharming is from now on and for the next 24 months, part of the ICEX-Next Export Initiation Program, with the support of ICEX and the co-financing of European FEDER fund. The purpose of this program is to contribute to design the strategy and to identify the necessary steps to develop the international expansion of the Tricopharming company and its products, including Artennua.

TRICOPHARMING ON THE SPANISH AGROTECH ECOSYSTEM MAP

150 150 marketing

El Referente, in collaboration with the EIT Food iVZW organization founded by the European Union, has published the Map of the Agrotech ecosystem in Spain, made up of public-private actors and 143 startups, among which we have been highlighted as a company working on digitization and technological evolution within the agricultural world.

Thanks to the emergence of new projects and initiatives aimed at overcoming the difficulties of a sector that sometimes shows production systems stuck in the past. The report of investment in innovative companies in the Agri-Food-Tech world has increased by 15.5% in 2020, reaching $26.1 billion.

“The health and social crisis has reminded us that for employment, social activity and services to work, the primary sectors must do so. The 2020 scenario has brought back some general recognition to the agricultural and livestock sector, enhancing, in turn, debates on the quality and origin of products and evidencing the resilience and innovation opportunities existing in the primary sector.

Agrotech in Spain is one of the sectors that has experienced the greatest resilience and attraction of capital in 2020.

Read the full article here: https://elreferente.es/scouting/mapa-ecosistema-agrotech-espana-2021-eit-food/

WE ARE COMMITTED TO YOUTH EMPLOYMENT

150 150 marketing

We have received recognition from the Chamber of Commerce of Santa Cruz de Tenerife for our contribution to youth employment. This recognition is due to our collaboration in the Integral Program of Qualification and Employment (PICE) and our commitment to improve the employability rates of young people under 30 years old.

The company Biotech Tricopharming Research SL has been the beneficiary of a hiring aid, within the Youth Employment Initiative of the European Social Fund and with the co-financing of the Cabildo de Tenerife, whose objective is to integrate into the labor market young people who do not work, study or receive training, in order to promote the labor market integration of the young population. It has been supported by the PICE program of the Chamber of Commerce, Industry, Services and Navigation of Santa Cruz de Tenerife.

GOOD RESULTS FOR THE BIOMAPPs PROJECT FINANCED BY ICEX AND FEDER FUND

150 150 marketing

We thank ICEX España Exportación e Inversiones and the European Regional Development Fund for their support in our project BIOMAPs: Research on new industrial applications of Artennua® and identification and development of new biostimulants.

In the framework of the project, the results of our research in 2020 on Artennua® derivatives in industrial applications such as biocides, food preservatives and flavorings were very promising.

Moreover, thanks to the BIOMAPPs project we could accelerate the trials on optimization of different medicinal and aromatic plants species cultivation with the application of our technology ᴛʀɪᴄᴏsᴛɪᴍᴜʟᴀɴᴛ™.

BIOVEGEN’S XV MEETING OF PLANT MOLECULAR BIOLOGY

150 150 marketing

Within the framework of the XV Meeting of Plant Molecular Biology organized by the Spanish Technology Platform for Plant Biotechnology BIOVEGEN, the “COMPANY-FINANCING R&D Session” will be celebrated. As part of the association we have the honor to be represented by the founder, scientist and CEO of Biotech Tricopharming Research SL, Luis Matías Hernández. The objective of the session will be to present TRICOPHARMING’s experience as a source of innovation, its business development strategy and the advances in the R&D projects carried out and in progress. The session will be carried out this 27th of November via online. 

Here is the preliminary program:

Moderator: Gonzaga Ruiz de Gauna. BIOVEGEN
11:00 h

Innovation companies:

  • DVA IBERIA. Andrés de La Cruz. Director of Crop Protection.
  • MAFA BIOSCIENCE. Hanan El Bakkali. Director of Regulatory Affairs.
  • TRICOPHARMING- Luis Matías Hernández. CEO and Co-Founder.
  • TARAZONA. Sergio Monzón. Director of Innovation and R+D.

Management and financing: 

  • CDTI-Centro Desarrollo Tecnológico Industrial. Carlos Sanchez. Biotechnology and Agrifood Department.
  • AEI-State Research Agency. Mª Ángeles Ferre. Thematic Scientific-Technical Programs.
  • BIOVEGEN-Technological Platform of Plant Biotechnology. Gonzaga Ruiz de Gauna. Coordinator.

WE ARE A NEW SEFIT CORPORATE PARTNER

150 150 marketing

We are pleased to announce that from this month we are a corporate partner of the Spanish Society of Phytotherapy SEFIT, which brings together professionals from various fields working in the study and the therapeutic application of medicinal plants.

Being part of SEFIT helps us to promote our research and spread our work with medicinal and aromatic plants (MAPs) which aims not only to increase the therapeutic potential of various MAPs, but also to research and find new uses and therapeutic applications in order to promote population health.

read more

MEDICINAL AND AROMATIC PLANTS TO FIGHT AGAINST COVID-19

150 150 marketing

We continue working in our research to collaborate with a treatment for the COVID-19.

Watch the CMM Castilla-La Mancha Media interview about our work with Artemisia annua and its possible application in the fight against the virus.

read more

TRICOPHARMING, A LEADING COMPANY THAT ANTICIPATE TOMORROW

150 150 marketing

Our company Tricopharming was included by the ABC newspaper in the top of the biotechnology and ICT companies that are committed to development and innovation in Spain thanks to our biotechnology based on biopharmaceutical agriculture and our first success case Artennua®, a optimized version of Artemisia annua.

read more